Merck KGaA's biosimilars business
GPTKB entity
Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biosimilars business
|
| gptkbp:aimsTo |
treatment costs
therapeutic options increase patient access to biologics |
| gptkbp:collaboratesWith |
healthcare_providers
|
| gptkbp:competesWith |
other biosimilars manufacturers
|
| gptkbp:contributedTo |
affordable healthcare
|
| gptkbp:develops |
therapeutic proteins
|
| gptkbp:focusesOn |
biopharmaceuticals
autoimmune disease biosimilars oncology biosimilars |
| gptkbp:hasEstablished |
partnerships with healthcare organizations
|
| gptkbp:hasEvents |
multiple product launches
|
| gptkbp:hasPart |
clinical trials
|
| https://www.w3.org/2000/01/rdf-schema#label |
Merck KGaA's biosimilars business
|
| gptkbp:investmentFocus |
research and development
|
| gptkbp:isAssignedTo |
healthcare trends
|
| gptkbp:isDedicatedTo |
patient safety
|
| gptkbp:isEngagedIn |
patient support services
collaborative research projects patient education initiatives advocacy for biosimilars |
| gptkbp:isFocusedOn |
quality assurance
sustainability practices market expansion cost-effective solutions patient-centric approaches |
| gptkbp:isInvolvedIn |
supply chain management
global health initiatives market access strategies health policy discussions educational programs for healthcare professionals clinical development programs healthcare_innovation |
| gptkbp:isKnownFor |
high-quality biosimilars
|
| gptkbp:isLocatedIn |
gptkb:Darmstadt,_Germany
|
| gptkbp:isPartOf |
gptkb:Merck_Group
biopharmaceutical industry biotechnology sector global biosimilars market |
| gptkbp:isRated |
patient needs
|
| gptkbp:isRecognizedFor |
scientific excellence
contribution to healthcare innovation in biosimilars |
| gptkbp:isSubjectTo |
regulatory scrutiny
|
| gptkbp:isSupportedBy |
regulatory frameworks
scientific research clinical evidence |
| gptkbp:offers |
biosimilar drugs
|
| gptkbp:operatesIn |
global markets
|
| gptkbp:partOf |
Merck KGaA
|
| gptkbp:regulatoryCompliance |
biosimilar products
|
| gptkbp:targets |
chronic diseases
|
| gptkbp:utilizes |
advanced manufacturing technologies
|